Ticker >

Arvee Laboratories share price

Arvee Laboratories (India) Ltd.

NSE: ARVEE SECTOR: Chemicals  15k   23   2

291.40
-15.30 (-4.99%)
NSE: 12 Apr 03:48 PM

Price Summary

Today's High

₹ 315

Today's Low

₹ 291.4

52 Week High

₹ 315

52 Week Low

₹ 98.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

321.12 Cr.

Enterprise Value

321.23 Cr.

No. of Shares

1.1 Cr.

P/E

339.83

P/B

11.08

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  26.31

CASH

0.89 Cr.

DEBT

1 Cr.

Promoter Holding

73.5 %

EPS (TTM)

₹  0.86

Sales Growth

52.12%

ROE

15.84 %

ROCE

23.35%

Profit Growth

60.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year52.12%
3 Year10.54%
5 Year5.13%

Profit Growth

1 Year60.04%
3 Year21.46%
5 Year30.48%

ROE%

1 Year15.84%
3 Year13.53%
5 Year13.75%

ROCE %

1 Year23.35%
3 Year17.56%
5 Year16.51%

Debt/Equity

0.0356

Price to Cash Flow

109.64

Interest Cover Ratio

16.8919589117014

CFO/PAT (5 Yr. Avg.)

2.04009324613991

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 73.5 0
Dec 2023 73.5 0
Sep 2023 73.5 0
Jun 2023 73.5 0
Mar 2023 73.5 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.131365 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 16.8919589117014.
  • The company has an efficient Cash Conversion Cycle of 21.0259597196432 days.
  • Company has a healthy liquidity position with current ratio of 2.44011903465007.
  • The company has a good cash flow management; CFO/PAT stands at 2.04009324613991.
  • The company has a high promoter holding of 73.5%.

 Limitations

  • The company has shown a poor revenue growth of 10.5399612731665% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 82.9406.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 16.25 12.56 7.6 8.91 7.7
Total Expenditure 14.51 11.4 6.61 8.22 7.17
Operating Profit 1.74 1.16 0.98 0.69 0.52
Other Income 0.07 0.06 0.09 0.09 0.19
Interest 0.09 0.07 0.07 0.08 0.05
Depreciation 0.49 0.48 0.35 0.42 0.35
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.23 0.67 0.65 0.28 0.32
Tax 0.31 0.66 0.16 0.07 0.08
Profit After Tax 0.92 0.01 0.49 0.21 0.24
Adjusted EPS (Rs) 0.83 0.01 0.44 0.19 0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 54.9 45.42 47.38 40.33 61.35
Total Expenditure 48.73 39.4 41.34 34.7 54.07
Operating Profit 6.17 6.02 6.04 5.62 7.28
Other Income 0.35 0.35 0.58 0.52 1.35
Interest 1.63 0.99 0.58 0.37 0.39
Depreciation 2.35 2.29 2.41 2.32 2.08
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.54 3.09 3.64 3.45 6.17
Tax 0.28 0.79 0.96 0.88 2.05
Net Profit 2.26 2.3 2.68 2.57 4.12
Adjusted EPS (Rs.) 2.05 2.09 2.43 2.34 3.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 5.51 5.51 11.02 11.02 11.02
Total Reserves 10.95 13.25 10.42 12.92 17.04
Borrowings 3.47 1.96 1 1 1
Other N/C liabilities 0.57 0.42 0.31 0.2 0.78
Current liabilities 16.65 12.49 18.29 13.54 8.84
Total Liabilities 37.15 33.62 41.05 38.68 38.69
Assets
Net Block 12.65 13.18 13.81 13.84 12.68
Capital WIP 2.32 1.78 0.97 0.98 1.53
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.57 0.69 0.65 0.17 0.54
Other N/C Assets 0.19 0.13 0.07 0 2.36
Current Assets 21.42 17.84 25.55 23.69 21.57
Total Assets 37.15 33.62 41.05 38.68 38.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 2.54 3.09 3.64 3.45 6.17
Adjustment 3.5 2.9 2.4 2.3 2.16
Changes in Assets & Liabilities 3.76 5.12 -3.37 -0.78 -3.64
Tax Paid -0.28 -0.79 -0.96 -0.95 -1.75
Operating Cash Flow 9.46 10.31 1.71 4.02 2.93
Investing Cash Flow -2.85 -3.08 -0.6 0.06 -1.26
Financing Cash Flow -4.92 -9.9 4.52 -6.05 -2.42
Net Cash Flow 1.68 -2.67 5.63 -1.98 -0.75

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 73.50 73.50 73.50 73.50 73.50
chandrabalaben patel 0.02 0.02 0.02 0.02 0.02
forum saumil chokshi - 0.02 0.02 0.02 0.02
kavita shalin chokshi 12.15 12.15 12.15 12.15 12.15
khushbuben shalinbhai pat... 0.02 - 0.02 0.02 0.02
mitaben bharatbhai choksh... 24.57 24.57 24.57 24.57 24.57
shalin bharatbhai chokshi... 0.01 0.01 0.01 0.01 0.01
shalin sudhakarbhai patel... 36.68 36.68 - 36.68 36.68
shalinbhai sudhakarbhai p... 0.02 0.02 0.02 0.02 0.02
sudhakar chhotabhai patel... 0.02 0.02 0.02 0.02 0.02
nshalin sudhakarbhai pate... - - 36.68 - -
khushbuben shalin patel - 0.02 - - -
forum shalin chokshi 0.02 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 26.50 26.50 26.50 26.50 26.50
deval pranav patel - - 5.19 5.19 5.19
gitaben dinehsbhai patel - - 9.98 - 9.98
jashbhai patel 4.79 4.79 4.79 4.79 4.79
madhuben jashbhai patel 3.70 3.70 3.70 3.70 3.70
gitaben dineshbhai patel 9.98 9.98 - 9.98 -
pranav m patel 5.19 5.19 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Arvee Laboratories Stock Price Analysis and Quick Research Report. Is Arvee Laboratories an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Arvee Laboratories has a PE ratio of 339.825072886297 which is high and comparatively overvalued .

  • Share Price: - The current share price of Arvee Laboratories is Rs 291.4. One can use valuation calculators of ticker to know if Arvee Laboratories share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Arvee Laboratories has ROA of 10.6475276996824 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Arvee Laboratories has a Current ratio of 2.44011903465007 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Arvee Laboratories has a ROE of 15.8429612899603 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Arvee Laboratories has a D/E ratio of 0.0356 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Arvee Laboratories has an Inventory turnover ratio of 11.9169495902735 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Arvee Laboratories has reported revenue growth of 52.1223650463119 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Arvee Laboratories for the current financial year is 11.8694656300905 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Arvee Laboratories is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Arvee Laboratories
X